Systematic Review of Factors Affecting Quality of Life After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy

BACKGROUND: Previous studies have shown that, overall, quality of life (QoL) decreases within the first 3–6 months after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC), returning to baseline levels by 6–12 months. This systematic review aims to evaluate the factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Leimkühler, Maleen, Hentzen, Judith E. K. R., Hemmer, Patrick H. J., Been, Lukas B., van Ginkel, Robert J., Kruijff, Schelto, van Leeuwen, Barbara L., de Bock, Geertruida H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Peritoneal Surface Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471142/
https://www.ncbi.nlm.nih.gov/pubmed/32335752
http://dx.doi.org/10.1245/s10434-020-08379-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471142/
https://www.ncbi.nlm.nih.gov/pubmed/32335752
http://dx.doi.org/10.1245/s10434-020-08379-9

Ejemplares similares